Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.2%

5 terminated/withdrawn out of 41 trials

Success Rate

75.0%

-11.6% vs industry average

Late-Stage Pipeline

2 trials in Phase 3/4

Results Transparency

1 of 15 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment reporting

Analytics

N/A

25(78.1%)

Phase 2

3(9.4%)

Phase 1

1(3.1%)

Phase 1/2

1(3.1%)

Phase 4

1(3.1%)

Phase 3

1(3.1%)

32Total

N/A(25)

Phase 2(3)

Phase 1(1)

Phase 1/2(1)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (41)

Showing 20 of 41 trials

NCT05214365Not ApplicableActive Not Recruiting

Physiological Pacing for AV Block to Prevent Pacemaker-induced Cardiomyopathy

Role: collaborator

NCT06127511Not ApplicableCompleted

Peanut Consumption on Cognitive, Weight, and Inflammation

Role: collaborator

NCT07687368Not ApplicableCompleted

Clinical Trial Protocol for Continuous Glucose Monitoring in Critical Care

Role: lead

NCT06105580Not ApplicableRecruiting

Conduction System Pacing vs Biventricular Pacing in Systolic Dysfunction and Wide QRS: Mortality, Heart Failure Hospitalization or Cardiac Transplant

Role: collaborator

NCT07479329Not Yet Recruiting

Estimated Risk of Preeclampsia in the First Trimester and Its Association With Subclinical Atherosclerosis and Cardiovascular Risk in Women With Type 1 Diabetes

Role: lead

NCT05612919Not ApplicableCompleted

Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants

Role: collaborator

NCT05898113Not ApplicableCompleted

Effect of the Intake of Corbella Extra Virgin Olive Oil on the Microbiota-gut-brain Axis in Healthy Adults (HEVOOC)

Role: collaborator

NCT05086939Phase 3Active Not Recruiting

Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.

Role: collaborator

NCT04778579Phase 2Unknown

Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy

Role: collaborator

NCT06421402Unknown

K-HEALTH in AIR - Barcelona Pilot - Cohort

Role: lead

NCT06296433Not ApplicableUnknown

Extended Reality-Assisted Therapy for Chronic Pain Management

Role: lead

NCT05080894Not ApplicableCompleted

Virtual Reality Rehabilitation for Patients With Anterior Cruciate Ligament Reconstruction

Role: lead

NCT06360809Not ApplicableUnknown

Prehabilitation Exercise Program in Breast Cancer: Effects on Quality of Life and Tumor Microenvironment (PEP_BC)

Role: collaborator

NCT05038462Not ApplicableRecruiting

Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction

Role: lead

NCT04005105Not ApplicableCompleted

Acute Post-cardiac Surgery Renal Failure: Prevention Through Individualized Intensive Hemodynamic Management

Role: collaborator

NCT04244331Terminated

DETERMINATION OF THE CELL OF ORIGIN (COO) in LDCGB

Role: collaborator

NCT04988633Not ApplicableCompleted

"CAP" Fetge Gras. Lifestyle Modification Program in Catalonia.

Role: collaborator

NCT05912062Unknown

Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer

Role: collaborator

NCT04120415Phase 2Completed

A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)

Role: collaborator

NCT05285969Not ApplicableUnknown

Cardiac Rehabilitation With Motivational Interview for Acute Myocardial Infarction

Role: collaborator